CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Executive or director change
- 8-K Event Shareholder rights changed
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K/A Event Exhibits
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
Page 2 of 4 · 70 filings